Agata WnęK
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Agata WnęK has a total of 24 co-authors. Here are the top co-authors by number of shared publications:
- Alicja Biskup
Uniwersyteckie Centrum Stomatologii Śląskiego Uniwersytetu Medycznego w Katowicach sp.z o.o., Bytom, Poland
12 shared publications - Ewa Kala-Kaziszyn
Stomatologia Adeeb Clinic Wahab Adeeb w Dąbrowie Górniczej
7 shared publications - Julia Smagowska
Uniwersyteckie Centrum Stomatologii Śląskiego Uniwersytetu Medycznego w Katowicach sp.z o.o., Bytom
6 shared publications - Zuzanna Hucała
Wojskowy Szpital Kliniczny z Polikliniką SPZOZ, Kraków, Poland
4 shared publications - Natasza Jankowska
5th Military Clinical Hospital with Polyclinic – Independent Public Healthcare Institution, Krakow, Poland
3 shared publications - Paulina Patrycja Turzyńska
University Clinical Center in Gdansk
3 shared publications
Latest Publications
- Open Access
- 25 September 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 5 (3(51))
PHOTOBIOMODULATION IN THE MANAGEMENT OF PAIN, EDEMA, AND TRISMUS AFTER IMPACTED THIRD MOLAR SURGERY: THE ROLE OF BIOPTRON POLARIZED LIGHT IN CURRENT EVIDENCE
Background. Surgical extraction of impacted third molars is often followed by pain, edema, and trismus, which may impair oral function and daily activities during early healing. Photobiomodulation therapy, including low-level laser, LED, and polarized polychromatic non-coherent light, has been investigated as a non-invasive adjunct for reducing postoperative morbidity. Bioptron delivers polarized polychromatic non-coherent light, but evidence for its use in oral surgery is limited. Aim. This narrative review evaluates evidence on photobiomodulation in the management of complications after impacted third molar surgery, with emphasis on the role of Bioptron polarized light therapy. Material and methods. A literature search was conducted in PubMed/MEDLINE, Scopus, Web of Science, Cochrane Library, and Google Scholar for publications from 2000 to 2025. Clinical trials, systematic reviews, meta-analyses, and relevant observational studies assessing photobiomodulation, laser therapy, LED therapy, or polarized light therapy in third molar surgery were included. Results. Evidence suggests that photobiomodulation may reduce postoperative pain, edema, and, to a lesser extent, trismus after third molar extraction, with the strongest support for laser and LED-based interventions. Proposed mechanisms include cytochrome c oxidase activation, increased ATP production, modulation of reactive oxygen species and inflammatory mediators, and enhanced wound healing. However, studies show heterogeneity in treatment parameters, timing, sessions, comparators, and outcome assessment. Evidence specifically addressing Bioptron in this indication remains sparse. Conclusions. Photobiomodulation appears safe and potentially useful after third molar surgery, but evidence supporting Bioptron polarized light remains insufficient. Randomized controlled trials with standardized protocols, sham controls, adequate sample sizes, and validated outcomes are needed.
- 25 September 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 5 (3(51))
Open AccessPHOTOBIOMODULATION IN THE MANAGEMENT OF PAIN, EDEMA, AND TRISMUS AFTER IMPACTED THIRD MOLAR SURGERY: THE ROLE OF BIOPTRON POLARIZED LIGHT IN CURRENT EVIDENCE
Background. Surgical extraction of impacted third molars is often followed by pain, edema, and trismus, which may impair oral function and daily activities during early healing. Photobiomodulation therapy, including low-level laser, LED, and polarized polychromatic non-coherent light, has been investigated as a non-invasive adjunct for reducing postoperative morbidity. Bioptron delivers polarized polychromatic non-coherent light, but evidence for its use in oral surgery is limited. Aim. This narrative review evaluates evidence on photobiomodulation in the management of complications after impacted third molar surgery, with emphasis on the role of Bioptron polarized light therapy. Material and methods. A literature search was conducted in PubMed/MEDLINE, Scopus, Web of Science, Cochrane Library, and Google Scholar for publications from 2000 to 2025. Clinical trials, systematic reviews, meta-analyses, and relevant observational studies assessing photobiomodulation, laser therapy, LED therapy, or polarized light therapy in third molar surgery were included. Results. Evidence suggests that photobiomodulation may reduce postoperative pain, edema, and, to a lesser extent, trismus after third molar extraction, with the strongest support for laser and LED-based interventions. Proposed mechanisms include cytochrome c oxidase activation, increased ATP production, modulation of reactive oxygen species and inflammatory mediators, and enhanced wound healing. However, studies show heterogeneity in treatment parameters, timing, sessions, comparators, and outcome assessment. Evidence specifically addressing Bioptron in this indication remains sparse. Conclusions. Photobiomodulation appears safe and potentially useful after third molar surgery, but evidence supporting Bioptron polarized light remains insufficient. Randomized controlled trials with standardized protocols, sham controls, adequate sample sizes, and validated outcomes are needed.
- Open Access
- 24 September 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 5 (3(51))
ORAL HEALTH IN PREGNANT WOMEN AND OBSTETRIC COMPLICATIONS: A NARRATIVE REVIEW OF EVIDENCE ON PRETERM BIRTH, LOW BIRTH WEIGHT, PREECLAMPSIA, AND GESTATIONAL DIABETES MELLITUS
Background and Objectives: Periodontitis affects approximately 40% of pregnant women worldwide, although prevalence estimates vary considerably depending on diagnostic criteria and population characteristics [7]. Periodontal disease is considered a potentially modifiable risk factor for adverse pregnancy outcomes (APOs). This narrative review examines the current evidence linking maternal periodontal disease to four major obstetric complications: preterm birth (PTB), low birth weight (LBW), preeclampsia (PE) and gestational diabetes mellitus (GDM). A secondary aim was to assess the clinical evidence for periodontal treatment as a preventive strategy during pregnancy. Methods: A narrative synthesis of literature published between January 2015 and April 2025 was conducted using PubMed/MEDLINE, Cochrane Library, Google Scholar, Embase and Web of Science. Systematic reviews, meta-analyses, randomised controlled trials (RCTs), prospective cohort studies and case-control studies were included. Quality appraisal was performed using AMSTAR-2, the Newcastle-Ottawa Scale and the Cochrane Risk of Bias 2.0 tool. Results: Consistent epidemiological associations were identified for all four outcomes. Effect sizes ranged from OR 1.67–4.28 for PTB, OR 1.82–2.53 for LBW and OR 1.83 for GDM, whereas the evidence for preeclampsia was classified as suggestive. Two mechanistic pathways were characterised: direct hematogenous translocation of periodontal pathogens to the fetoplacental unit and an indirect systemic inflammatory cascade mediated by IL-1β, IL-6, TNF-α and prostaglandin E2. Intervention trials demonstrated that non-surgical scaling and root planing (SRP) is safe for pregnant women but does not produce a consistent, statistically significant reduction in APO rates. Conclusions: Maternal periodontitis is significantly associated with PTB, LBW, GDM and PE through biologically plausible mechanisms. However, causal inference is hampered by heterogeneous disease definitions, residual confounding and inconsistent RCT results. Integration of oral health screening into antenatal care protocols and standardisation of periodontal diagnostic criteria in obstetric research are priority recommendations.
- 24 September 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 5 (3(51))
Open AccessORAL HEALTH IN PREGNANT WOMEN AND OBSTETRIC COMPLICATIONS: A NARRATIVE REVIEW OF EVIDENCE ON PRETERM BIRTH, LOW BIRTH WEIGHT, PREECLAMPSIA, AND GESTATIONAL DIABETES MELLITUS
Background and Objectives: Periodontitis affects approximately 40% of pregnant women worldwide, although prevalence estimates vary considerably depending on diagnostic criteria and population characteristics [7]. Periodontal disease is considered a potentially modifiable risk factor for adverse pregnancy outcomes (APOs). This narrative review examines the current evidence linking maternal periodontal disease to four major obstetric complications: preterm birth (PTB), low birth weight (LBW), preeclampsia (PE) and gestational diabetes mellitus (GDM). A secondary aim was to assess the clinical evidence for periodontal treatment as a preventive strategy during pregnancy. Methods: A narrative synthesis of literature published between January 2015 and April 2025 was conducted using PubMed/MEDLINE, Cochrane Library, Google Scholar, Embase and Web of Science. Systematic reviews, meta-analyses, randomised controlled trials (RCTs), prospective cohort studies and case-control studies were included. Quality appraisal was performed using AMSTAR-2, the Newcastle-Ottawa Scale and the Cochrane Risk of Bias 2.0 tool. Results: Consistent epidemiological associations were identified for all four outcomes. Effect sizes ranged from OR 1.67–4.28 for PTB, OR 1.82–2.53 for LBW and OR 1.83 for GDM, whereas the evidence for preeclampsia was classified as suggestive. Two mechanistic pathways were characterised: direct hematogenous translocation of periodontal pathogens to the fetoplacental unit and an indirect systemic inflammatory cascade mediated by IL-1β, IL-6, TNF-α and prostaglandin E2. Intervention trials demonstrated that non-surgical scaling and root planing (SRP) is safe for pregnant women but does not produce a consistent, statistically significant reduction in APO rates. Conclusions: Maternal periodontitis is significantly associated with PTB, LBW, GDM and PE through biologically plausible mechanisms. However, causal inference is hampered by heterogeneous disease definitions, residual confounding and inconsistent RCT results. Integration of oral health screening into antenatal care protocols and standardisation of periodontal diagnostic criteria in obstetric research are priority recommendations.
- Open Access
- 28 August 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 2 (3(51))
NEURO-ENDOCRINE-IMMUNE CROSSTALK IN CHRONIC DISEASES: AN INTEGRATIVE REVIEW OF MOLECULAR MECHANISMS, BIOMARKERS, AND PREVENTIVE STRATEGIES
Background: The growing burden of chronic non-communicable diseases has highlighted the importance of the neuro-endocrine-immune (NEI) axis as a central regulatory network integrating neural, endocrine, and immune signaling to maintain physiological homeostasis and coordinate adaptive responses to internal and environmental challenges. Increasing evidence indicates that disruption of this bidirectional communication contributes to chronic low-grade inflammation, impaired stress adaptation, and the development of multiple chronic diseases. Objective: This integrative review aims to synthesize current evidence on the molecular mechanisms, regulatory networks, biomarkers, and translational implications of neuro-endocrine-immune crosstalk, with particular emphasis on its relevance for preventive strategies and personalized medicine. Materials and Methods: An integrative review of peer-reviewed literature indexed in PubMed, Scopus, and Web of Science was conducted. The available evidence was synthesized to identify key molecular pathways, neuroimmune regulatory mechanisms, environmental sensing pathways, and clinically relevant biomarkers associated with neuro-endocrine-immune (NEI) dysregulation. Results: The available evidence indicates that disruption of NEI crosstalk promotes persistent inflammatory activation, autonomic imbalance, impaired glucocorticoid signaling, and immune dysregulation, thereby contributing to the initiation and progression of major chronic diseases. Inflammatory mediators, cortisol dynamics, autonomic indices, microbiota-derived metabolites, and environmental sensing pathways have emerged as promising biomarkers and therapeutic targets for disease prevention and risk stratification. Conclusions: The NEI axis represents a fundamental systems-level interface linking environmental exposures, stress responses, and chronic disease development. A deeper understanding of NEI crosstalk provides a scientific basis for identifying clinically relevant biomarkers and supports the development of predictive, preventive, personalized, and participatory strategies for chronic disease prevention and management.
- 28 August 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 2 (3(51))
Open AccessNEURO-ENDOCRINE-IMMUNE CROSSTALK IN CHRONIC DISEASES: AN INTEGRATIVE REVIEW OF MOLECULAR MECHANISMS, BIOMARKERS, AND PREVENTIVE STRATEGIES
Background: The growing burden of chronic non-communicable diseases has highlighted the importance of the neuro-endocrine-immune (NEI) axis as a central regulatory network integrating neural, endocrine, and immune signaling to maintain physiological homeostasis and coordinate adaptive responses to internal and environmental challenges. Increasing evidence indicates that disruption of this bidirectional communication contributes to chronic low-grade inflammation, impaired stress adaptation, and the development of multiple chronic diseases. Objective: This integrative review aims to synthesize current evidence on the molecular mechanisms, regulatory networks, biomarkers, and translational implications of neuro-endocrine-immune crosstalk, with particular emphasis on its relevance for preventive strategies and personalized medicine. Materials and Methods: An integrative review of peer-reviewed literature indexed in PubMed, Scopus, and Web of Science was conducted. The available evidence was synthesized to identify key molecular pathways, neuroimmune regulatory mechanisms, environmental sensing pathways, and clinically relevant biomarkers associated with neuro-endocrine-immune (NEI) dysregulation. Results: The available evidence indicates that disruption of NEI crosstalk promotes persistent inflammatory activation, autonomic imbalance, impaired glucocorticoid signaling, and immune dysregulation, thereby contributing to the initiation and progression of major chronic diseases. Inflammatory mediators, cortisol dynamics, autonomic indices, microbiota-derived metabolites, and environmental sensing pathways have emerged as promising biomarkers and therapeutic targets for disease prevention and risk stratification. Conclusions: The NEI axis represents a fundamental systems-level interface linking environmental exposures, stress responses, and chronic disease development. A deeper understanding of NEI crosstalk provides a scientific basis for identifying clinically relevant biomarkers and supports the development of predictive, preventive, personalized, and participatory strategies for chronic disease prevention and management.
- Open Access
- 26 August 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 2 (3(51))
ROLE OF PRO- AND ANTI-INFLAMMATORY INTERLEUKINS IN PERIODONTITIS: MOLECULAR, IMMUNOLOGICAL, AND THERAPEUTIC SIGNIFICANCE
Periodontitis is a chronic, biofilm-associated inflammatory disease in which tissue destruction reflects an altered host immune response more than the direct action of bacteria alone. This structured narrative review examines the molecular, immunological, diagnostic, and therapeutic significance of pro- and anti-inflammatory interleukins in periodontitis. A targeted literature search was performed in PubMed/MEDLINE, PubMed Central, Scopus, Web of Science, and Google Scholar for English-language publications from 2016 to 2026. Search terms combined 'periodontitis,' 'periodontal disease,' 'interleukin,' 'cytokine,' 'IL-1β,' 'IL-6,' 'IL-10,' 'IL-17,' 'IL-23,' 'IL-33,' 'IL-35,' 'IL-38,' 'inflammasome,' 'saliva,' and 'gingival crevicular fluid.' In the expanded search, 106 records were screened by title and abstract, 53 full-text papers were assessed, and 35 peer-reviewed publications were selected because they directly addressed interleukin expression, signaling, biomarker value, genetic variation, or therapeutic modulation in periodontal disease. Overall, IL-1β and IL-6 remain the most consistent salivary and gingival crevicular fluid biomarkers of disease severity. The IL-23/IL-17 pathway links adaptive immunity with neutrophil recruitment, RANKL expression, and osteoclastogenesis, whereas IL-10, IL-35, and IL-38 illustrate the importance of regulatory cytokine networks. Interleukin-directed therapy is not yet ready for routine periodontal use, but local, phenotype-guided immunomodulation may become a rational adjunct to conventional periodontal treatment.
- 26 August 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 2 (3(51))
Open AccessROLE OF PRO- AND ANTI-INFLAMMATORY INTERLEUKINS IN PERIODONTITIS: MOLECULAR, IMMUNOLOGICAL, AND THERAPEUTIC SIGNIFICANCE
Periodontitis is a chronic, biofilm-associated inflammatory disease in which tissue destruction reflects an altered host immune response more than the direct action of bacteria alone. This structured narrative review examines the molecular, immunological, diagnostic, and therapeutic significance of pro- and anti-inflammatory interleukins in periodontitis. A targeted literature search was performed in PubMed/MEDLINE, PubMed Central, Scopus, Web of Science, and Google Scholar for English-language publications from 2016 to 2026. Search terms combined 'periodontitis,' 'periodontal disease,' 'interleukin,' 'cytokine,' 'IL-1β,' 'IL-6,' 'IL-10,' 'IL-17,' 'IL-23,' 'IL-33,' 'IL-35,' 'IL-38,' 'inflammasome,' 'saliva,' and 'gingival crevicular fluid.' In the expanded search, 106 records were screened by title and abstract, 53 full-text papers were assessed, and 35 peer-reviewed publications were selected because they directly addressed interleukin expression, signaling, biomarker value, genetic variation, or therapeutic modulation in periodontal disease. Overall, IL-1β and IL-6 remain the most consistent salivary and gingival crevicular fluid biomarkers of disease severity. The IL-23/IL-17 pathway links adaptive immunity with neutrophil recruitment, RANKL expression, and osteoclastogenesis, whereas IL-10, IL-35, and IL-38 illustrate the importance of regulatory cytokine networks. Interleukin-directed therapy is not yet ready for routine periodontal use, but local, phenotype-guided immunomodulation may become a rational adjunct to conventional periodontal treatment.
- Open Access
- 7 August 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 67
Sleep Loss and Post-Exercise Muscle Recovery Hormonal, Inflammatory, Metabolic and Circadian Mechanisms with Practical Implications for Athletes
Introduction and aim: Sleep is essential for skeletal muscle repair, endocrine regulation, immune balance, metabolic homeostasis and adaptation to exercise. In athletes and physically active individuals, insufficient sleep may impair post-exercise recovery and reduce physical performance. The aim of this review was to analyze the hormonal, inflammatory, metabolic and circadian mechanisms through which sleep deprivation may affect skeletal muscle recovery after exercise. Materials and methods: This narrative review was based on a literature search conducted in PubMed, Scopus, Web of Science and Google Scholar. The analysis included systematic reviews, meta-analyses, randomized and controlled human studies, experimental sleep restriction studies and selected animal or cellular studies that provided relevant mechanistic explanations. Publications concerning sleep deprivation, exercise recovery, skeletal muscle metabolism, hormonal regulation, inflammation, mitochondrial function, circadian rhythm and physical performance were included. Results: Available evidence indicates that sleep deprivation may disturb the GH/IGF-1 axis, increase cortisol activity, alter testosterone secretion, promote inflammatory dysregulation, reduce myofibrillar protein synthesis, impair mitochondrial function, decrease insulin sensitivity and disrupt skeletal muscle circadian regulation. These mechanisms may contribute to impaired muscle repair, reduced recovery capacity and less favorable training adaptation. Conclusions: Sleep should be regarded as an active component of post-exercise recovery rather than a passive period of rest. Sleep optimization, sleep extension before anticipated sleep loss, strategic napping, appropriate training load adjustment and adequate nutrition may support recovery in athletes and physically active individuals. Further studies are needed to clarify dose-response relationships and to identify the most effective recovery strategies in real-world sports settings.
- 7 August 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 67
Open AccessSleep Loss and Post-Exercise Muscle Recovery Hormonal, Inflammatory, Metabolic and Circadian Mechanisms with Practical Implications for Athletes
Introduction and aim: Sleep is essential for skeletal muscle repair, endocrine regulation, immune balance, metabolic homeostasis and adaptation to exercise. In athletes and physically active individuals, insufficient sleep may impair post-exercise recovery and reduce physical performance. The aim of this review was to analyze the hormonal, inflammatory, metabolic and circadian mechanisms through which sleep deprivation may affect skeletal muscle recovery after exercise. Materials and methods: This narrative review was based on a literature search conducted in PubMed, Scopus, Web of Science and Google Scholar. The analysis included systematic reviews, meta-analyses, randomized and controlled human studies, experimental sleep restriction studies and selected animal or cellular studies that provided relevant mechanistic explanations. Publications concerning sleep deprivation, exercise recovery, skeletal muscle metabolism, hormonal regulation, inflammation, mitochondrial function, circadian rhythm and physical performance were included. Results: Available evidence indicates that sleep deprivation may disturb the GH/IGF-1 axis, increase cortisol activity, alter testosterone secretion, promote inflammatory dysregulation, reduce myofibrillar protein synthesis, impair mitochondrial function, decrease insulin sensitivity and disrupt skeletal muscle circadian regulation. These mechanisms may contribute to impaired muscle repair, reduced recovery capacity and less favorable training adaptation. Conclusions: Sleep should be regarded as an active component of post-exercise recovery rather than a passive period of rest. Sleep optimization, sleep extension before anticipated sleep loss, strategic napping, appropriate training load adjustment and adequate nutrition may support recovery in athletes and physically active individuals. Further studies are needed to clarify dose-response relationships and to identify the most effective recovery strategies in real-world sports settings.
- Open Access
- 16 July 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 64, 73174
Creatine Supplementation in Sport and Medicine: Efficacy, Safety, and Therapeutic Potential in the Light of Current Scientific Evidence
Creatine is a naturally occurring compound stored mainly in skeletal muscles, where it plays an essential role in energy production during high-intensity exercise. Creatine monohydrate is one of the most widely studied and effective ergogenic supplements, shown to improve strength, anaerobic performance, muscle mass, and recovery. This paper reviews the current evidence on the effectiveness, safety, and applications of creatine supplementation in sports and health. In addition to its well-established benefits for athletic performance, emerging research suggests potential roles in neuroprotection, healthy aging, and rehabilitation. Current evidence indicates that creatine monohydrate is safe for both short- and long-term use when consumed according to recommended guidelines.
- 16 July 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 64, 73174
Open AccessCreatine Supplementation in Sport and Medicine: Efficacy, Safety, and Therapeutic Potential in the Light of Current Scientific Evidence
Creatine is a naturally occurring compound stored mainly in skeletal muscles, where it plays an essential role in energy production during high-intensity exercise. Creatine monohydrate is one of the most widely studied and effective ergogenic supplements, shown to improve strength, anaerobic performance, muscle mass, and recovery. This paper reviews the current evidence on the effectiveness, safety, and applications of creatine supplementation in sports and health. In addition to its well-established benefits for athletic performance, emerging research suggests potential roles in neuroprotection, healthy aging, and rehabilitation. Current evidence indicates that creatine monohydrate is safe for both short- and long-term use when consumed according to recommended guidelines.
- Open Access
- 14 July 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 64, 73626
Exercise-induced BDNF signaling mediates neuroplasticity in depression
Background.Major depressive disorder (MDD) is increasingly recognized as a disorder of impaired neuroplasticity. Brain-derived neurotrophic factor (BDNF) plays a central role in neuronal survival, synaptic plasticity, and antidepressant mechanisms [1–4]. Physical exercise has emerged as an effective non-pharmacological intervention capable of enhancing BDNF signaling and promoting neuroplastic adaptations [20–27]. Aim.To summarize current evidence on the role of exercise-induced BDNF signaling in mediating neuroplastic adaptations and antidepressant effects in depression. Material and methods.A narrative review of peer-reviewed studies, including mechanistic research, randomized controlled trials, cohort studies, and meta-analyses, was conducted. Evidence from neuroscience, exercise physiology, and clinical psychiatry was integrated. Results.Exercise increases BDNF expression through multiple biological pathways, including lactate signaling, muscle–brain crosstalk, and kynurenine metabolism [8–10]. These adaptations promote neurogenesis, synaptic plasticity, and improvements in brain connectivity [11,12,16,17]. Meta-analyses demonstrate that exercise increases circulating BDNF levels and reduces depressive symptoms [14,15,22]. Epidemiological and clinical studies indicate that higher physical activity is associated with a lower risk of depression and improved mental health outcomes [20–30]. Conclusions.BDNF appears to be a key mediator of the antidepressant effects of exercise. Current evidence supports the inclusion of structured physical activity as an evidence-based component of depression treatment, although further research is needed to optimize exercise protocols and clarify individual differences in BDNF responsiveness.
- 14 July 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 64, 73626
Open AccessExercise-induced BDNF signaling mediates neuroplasticity in depression
Background.Major depressive disorder (MDD) is increasingly recognized as a disorder of impaired neuroplasticity. Brain-derived neurotrophic factor (BDNF) plays a central role in neuronal survival, synaptic plasticity, and antidepressant mechanisms [1–4]. Physical exercise has emerged as an effective non-pharmacological intervention capable of enhancing BDNF signaling and promoting neuroplastic adaptations [20–27]. Aim.To summarize current evidence on the role of exercise-induced BDNF signaling in mediating neuroplastic adaptations and antidepressant effects in depression. Material and methods.A narrative review of peer-reviewed studies, including mechanistic research, randomized controlled trials, cohort studies, and meta-analyses, was conducted. Evidence from neuroscience, exercise physiology, and clinical psychiatry was integrated. Results.Exercise increases BDNF expression through multiple biological pathways, including lactate signaling, muscle–brain crosstalk, and kynurenine metabolism [8–10]. These adaptations promote neurogenesis, synaptic plasticity, and improvements in brain connectivity [11,12,16,17]. Meta-analyses demonstrate that exercise increases circulating BDNF levels and reduces depressive symptoms [14,15,22]. Epidemiological and clinical studies indicate that higher physical activity is associated with a lower risk of depression and improved mental health outcomes [20–30]. Conclusions.BDNF appears to be a key mediator of the antidepressant effects of exercise. Current evidence supports the inclusion of structured physical activity as an evidence-based component of depression treatment, although further research is needed to optimize exercise protocols and clarify individual differences in BDNF responsiveness.
- Open Access
- 13 July 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 63
The Association Between Sports Nutrition and Hard Dental Tissue Disorders in Athletes: A Systematic Review
Sports nutrition may influence oral health, particularly through frequent consumption of acidic and sugar-containing products such as isotonic drinks, energy drinks, and carbohydrate supplements. This systematic review evaluated the relationship between sports nutrition and dental hard tissue disorders, mainly dental caries and enamel erosion, in amateur and professional athletes. The reviewed studies suggest that athletes may be at increased risk of caries and enamel erosion due to the cariogenic and erosive potential of sports products. However, the evidence remains inconsistent, as oral health outcomes are also affected by factors such as salivary flow, hydration, fluoride exposure, oral hygiene, and remineralization capacity. Sports nutrition should therefore be regarded as a modifying rather than a direct causative factor in oral diseases. Preventive education and interdisciplinary cooperation between dentists, physicians, and dietitians are important for reducing oral health risks in athletes. Further longitudinal and interventional studies are needed to clarify these relationships.
- 13 July 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 63
Open AccessThe Association Between Sports Nutrition and Hard Dental Tissue Disorders in Athletes: A Systematic Review
Sports nutrition may influence oral health, particularly through frequent consumption of acidic and sugar-containing products such as isotonic drinks, energy drinks, and carbohydrate supplements. This systematic review evaluated the relationship between sports nutrition and dental hard tissue disorders, mainly dental caries and enamel erosion, in amateur and professional athletes. The reviewed studies suggest that athletes may be at increased risk of caries and enamel erosion due to the cariogenic and erosive potential of sports products. However, the evidence remains inconsistent, as oral health outcomes are also affected by factors such as salivary flow, hydration, fluoride exposure, oral hygiene, and remineralization capacity. Sports nutrition should therefore be regarded as a modifying rather than a direct causative factor in oral diseases. Preventive education and interdisciplinary cooperation between dentists, physicians, and dietitians are important for reducing oral health risks in athletes. Further longitudinal and interventional studies are needed to clarify these relationships.
- Open Access
- 7 July 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 61, 73015
Obesity and Periodontal Diseases: The Emerging Role of Metabolic Health and Chronic Inflammation in Oral Disease
Obesity is a chronic metabolic disease characterized by excessive adipose tissue accumulation and persistent low-grade systemic inflammation. Periodontitis is one of the most common chronic inflammatory diseases worldwide and represents a major cause of tooth loss in adults. Increasing evidence suggests that obesity may contribute to the development and progression of periodontal diseases through shared inflammatory and metabolic pathways. The aim of this review was to summarize current evidence regarding the relationship between obesity and periodontal diseases, with particular emphasis on biological mechanisms, epidemiological findings, and clinical implications. A narrative review of the literature was conducted using PubMed/MEDLINE, Scopus, and Web of Science databases. Available evidence consistently demonstrates a positive association between obesity and periodontitis. Meta-analyses report increased odds of periodontal disease among individuals with obesity, with estimated odds ratios ranging from 1.31 to 2.46. Proposed mechanisms include chronic low-grade inflammation, dysregulated adipokine secretion, enhanced osteoclastogenesis, insulin resistance, oxidative stress, and obesity-associated alterations in the oral and gut microbiome. Current evidence supports obesity as an important potential risk factor for periodontal diseases. The interaction between metabolic dysfunction and periodontal inflammation highlights the need for a multidisciplinary approach integrating oral health assessment with metabolic risk evaluation. Further prospective and interventional studies are required to clarify causality and determine whether weight reduction strategies can improve periodontal outcomes.
- 7 July 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 61, 73015
Open AccessObesity and Periodontal Diseases: The Emerging Role of Metabolic Health and Chronic Inflammation in Oral Disease
Obesity is a chronic metabolic disease characterized by excessive adipose tissue accumulation and persistent low-grade systemic inflammation. Periodontitis is one of the most common chronic inflammatory diseases worldwide and represents a major cause of tooth loss in adults. Increasing evidence suggests that obesity may contribute to the development and progression of periodontal diseases through shared inflammatory and metabolic pathways. The aim of this review was to summarize current evidence regarding the relationship between obesity and periodontal diseases, with particular emphasis on biological mechanisms, epidemiological findings, and clinical implications. A narrative review of the literature was conducted using PubMed/MEDLINE, Scopus, and Web of Science databases. Available evidence consistently demonstrates a positive association between obesity and periodontitis. Meta-analyses report increased odds of periodontal disease among individuals with obesity, with estimated odds ratios ranging from 1.31 to 2.46. Proposed mechanisms include chronic low-grade inflammation, dysregulated adipokine secretion, enhanced osteoclastogenesis, insulin resistance, oxidative stress, and obesity-associated alterations in the oral and gut microbiome. Current evidence supports obesity as an important potential risk factor for periodontal diseases. The interaction between metabolic dysfunction and periodontal inflammation highlights the need for a multidisciplinary approach integrating oral health assessment with metabolic risk evaluation. Further prospective and interventional studies are required to clarify causality and determine whether weight reduction strategies can improve periodontal outcomes.
- Open Access
- 25 June 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 59
Effects of Nonsteroidal Anti-Inflammatory Drugs on Muscle Hypertrophy, Connective Tissue Remodeling and Exercise Adaptation: A Narrative Review
Introduction and Purpose Exercise-induced inflammation plays an important role in skeletal muscle regeneration and adaptation to training. Nonsteroidal anti-inflammatory drugs (NSAIDs) are commonly used in sports medicine to reduce pain and inflammation; however, chronic suppression of inflammatory pathways may interfere with adaptive responses to exercise. The aim of this review was to analyze current evidence regarding the effects of NSAIDs on muscle hypertrophy, connective tissue remodeling, and exercise adaptation. Materials and Methods A narrative review was conducted using PubMed, Scopus, and Web of Science databases. Publications related to NSAIDs, exercise physiology, muscle hypertrophy, satellite cells, mTOR signaling, tendon remodeling, and gut-muscle axis interactions were analyzed. Particular attention was given to experimental studies, systematic reviews, and meta-analyses. Results Available evidence indicates that prolonged NSAID use may affect mechanisms involved in muscle regeneration and connective tissue remodeling. Chronic cyclooxygenase inhibition may influence prostaglandin synthesis, satellite cell activity, mTORC1 signaling, collagen turnover, and intestinal barrier integrity. The magnitude of these effects appears to depend on dosage, duration of use, timing of administration, age, and training characteristics. Young individuals exposed to high training loads may be particularly susceptible to altered adaptive responses. Conclusions NSAIDs remain valuable agents in short-term pain management; however, routine long-term use as a recovery strategy should be approached with caution. Current evidence suggests that chronic suppression of exercise-induced inflammation may influence physiological mechanisms responsible for muscle and connective tissue adaptation. Further long-term studies are required to determine the clinical significance of these effects in athletic populations.
- 25 June 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 59
Open AccessEffects of Nonsteroidal Anti-Inflammatory Drugs on Muscle Hypertrophy, Connective Tissue Remodeling and Exercise Adaptation: A Narrative Review
Introduction and Purpose Exercise-induced inflammation plays an important role in skeletal muscle regeneration and adaptation to training. Nonsteroidal anti-inflammatory drugs (NSAIDs) are commonly used in sports medicine to reduce pain and inflammation; however, chronic suppression of inflammatory pathways may interfere with adaptive responses to exercise. The aim of this review was to analyze current evidence regarding the effects of NSAIDs on muscle hypertrophy, connective tissue remodeling, and exercise adaptation. Materials and Methods A narrative review was conducted using PubMed, Scopus, and Web of Science databases. Publications related to NSAIDs, exercise physiology, muscle hypertrophy, satellite cells, mTOR signaling, tendon remodeling, and gut-muscle axis interactions were analyzed. Particular attention was given to experimental studies, systematic reviews, and meta-analyses. Results Available evidence indicates that prolonged NSAID use may affect mechanisms involved in muscle regeneration and connective tissue remodeling. Chronic cyclooxygenase inhibition may influence prostaglandin synthesis, satellite cell activity, mTORC1 signaling, collagen turnover, and intestinal barrier integrity. The magnitude of these effects appears to depend on dosage, duration of use, timing of administration, age, and training characteristics. Young individuals exposed to high training loads may be particularly susceptible to altered adaptive responses. Conclusions NSAIDs remain valuable agents in short-term pain management; however, routine long-term use as a recovery strategy should be approached with caution. Current evidence suggests that chronic suppression of exercise-induced inflammation may influence physiological mechanisms responsible for muscle and connective tissue adaptation. Further long-term studies are required to determine the clinical significance of these effects in athletic populations.